Determining the glycemic index of oral nutrition supplements
Glycaemic Index Determination in Oral Nutrition Supplements
This study tests how different oral nutrition supplements affect blood sugar levels in healthy volunteers to help people, especially those with diabetes, choose the best options for managing their blood sugar.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 15 (estimated) |
| Ages | 21 Years to 60 Years |
| Sex | All |
| Sponsor | Universitat de Lleida Academic / other |
| Locations | 1 site (Lleida) |
| Trial ID | NCT06358716 on ClinicalTrials.gov |
What this trial studies
This study aims to determine the glycemic index of nine different formulations of complete oral nutrition supplements. It will involve 15 healthy volunteers who will consume these supplements, and their blood glucose levels will be measured at various intervals to assess the glycemic response. The results will help classify these supplements based on their impact on blood glucose levels, which is crucial for individuals needing to manage their glycemic control, such as those with diabetes. The methodology follows the International Standard Organization guidelines for glycemic index determination.
Who should consider this trial
Good fit: Ideal candidates for this study are healthy volunteers without any known food allergies or conditions affecting glucose metabolism.
Not a fit: Patients with diabetes or those on medications that affect glucose tolerance will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help patients make better dietary choices to manage their blood glucose levels effectively.
How similar studies have performed: Previous studies have successfully determined glycemic indices for various foods, suggesting that this approach is well-established.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: • Healthy volunteers with no known food allergy or intolerance and pharmacological treatments known to affect glucose tolerance (excluding oral contraceptives) Exclusion Criteria: * Known history of diabetes mellitus or the use of antihyperglycemic drugs or insulin to treat diabetes and related conditions. * Any acute, chronic disease or any other serious complications that may interfere with glucose metabolism. * Subjects using any medication (eg steroids, protease inhibitors or antipsychotics, etc.) that would interfere with the digestion and nutrient absorption. * Subjects having gastrointestinal diseases that may interfere with nutrient absorption, distribution, metabolism, excretion * A major medical or surgical event requiring hospitalization within the preceding 3 months. * Pregnancy
Where this trial is running
Lleida
- University of Lleida — Lleida, Spain (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.